{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:34:14Z","timestamp":1787762054060,"version":"build-2784847793"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Acute myocardial infarction (AMI) and related cardiac conditions are leading global causes of mortality. Timely diagnosis and intervention in AMI are vital; however, existing biochemical markers such as myoglobin, creatine kinase-MB (CK-MB), and troponins have limitations in early detection. Heart-type fatty acid-binding protein (H-FABP), abundant in cardiac tissue, has emerged as a potential early biomarker for AMI. This study evaluates the diagnostic efficacy of H-FABP compared to troponin-T (Trop-T) and CK-MB, aiming to establish H-FABP as a reliable biomarker for early acute coronary syndrome (ACS) diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This prospective comparative cross-sectional study was conducted at KLES Dr. Prabhakar Kore Hospital from January to December 2023, enrolling 50 patients presenting with chest pain suggestive of ACS. Laboratory assessments were executed for cardiac Trop-T, CK-MB, and H-FABP. Trop-T and CK-MB levels were measured upon presentation and again 6\u201312 h postadmission, while H-FABP was qualitatively assessed at presentation only. Data on symptoms and medical history were recorded. Laboratory analyses utilized electrochemiluminescence immunoassay for Trop-T and CK-MB and rapid chromatographic immunoassay for H-FABP. The primary outcome was sensitivity for diagnosing ACS within the initial 3-h window, with secondary outcomes including specificity, positive predictive value, and negative predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mean age was 52.68 \u00b1 12 years, with a significant male predominance (74.4% in AMI). Typical chest pain was reported by 80% of patients. H-FABP showed 76.92% sensitivity, 100% specificity, and a highly significant\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.0001 within the 3-h window, while Trop-T\u2019s sensitivity improved over time from 35.90% at presentation to 84.60% at 6\u201312 h. CK-MB exhibited moderate sensitivity (43.59% at presentation and 66.70% at 6\u201312 h) and significant specificity (100%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study highlights clinical and diagnostic differences between AMI and UA. H-FABP demonstrated high diagnostic accuracy during the early hours of presentation, suggesting its potential as a valuable early biomarker for ACS diagnosis. However, larger multicentric studies are necessary to validate these findings before routine clinical adoption.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijciis.ijciis_63_25","type":"journal-article","created":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T06:00:20Z","timestamp":1771394420000},"page":"72-78","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the diagnostic utility of heart-type fatty acid-binding protein as a novel biomarker for acute coronary syndrome in the emergency department: A 1-year cross-sectional study"],"prefix":"10.4103","volume":"16","author":[{"given":"Raju H","family":"Badiger","sequence":"first","affiliation":[{"name":"Department of General Medicine, JNMC, KAHER, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SV","family":"Dinesha","sequence":"additional","affiliation":[{"name":"Department of General Medicine, JNMC, KAHER, Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,18]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: A report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"R2-20260518","first-page":"e144","article-title":"ACC\/AHA guideline for the management of patients with stable ischemic heart disease: A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Fihn","year":"2014","journal-title":"Circulation"},{"key":"R3-20260518","first-page":"23","article-title":"Understanding coronary heart disease: Epidemiology and management strategies","volume":"6","author":"Kuberan","year":"2017","journal-title":"J Clin Med"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"R5-20260518","first-page":"e29","article-title":"Heart disease and stroke statistics \u2013 2015 update: A report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1161\/01.STR.0000223048.70103.F1","article-title":"Guidelines for the primary prevention of stroke: A statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"37","author":"Goldstein","year":"2006","journal-title":"Stroke"},{"key":"R8-20260518","first-page":"322","article-title":"Chronic disease epidemiology: The real challenge for the twenty-first century","volume":"11","author":"Sinha","year":"2019","journal-title":"N Am J Med Sci"},{"key":"R9-20260518","first-page":"1825","article-title":"Insights into the origins of cardiovascular disease: The role of epidemiologic studies","volume":"357","author":"Vasan","year":"2001","journal-title":"Lancet"},{"key":"R10-20260518","first-page":"949","article-title":"Tracking the decline in coronary heart disease: Is it a cause for celebration?","volume":"96","author":"Capewell","year":"2010","journal-title":"Heart"},{"key":"R11-20260518","first-page":"1360","article-title":"Global, regional, and national comparative risk assessment of cardiovascular diseases","volume":"388","author":"Forouzanfar","year":"2016","journal-title":"Lancet"},{"key":"R12-20260518","first-page":"e982","article-title":"Advancing cardiovascular health in the United States: A scientific statement from the American Heart Association","volume":"139","author":"Mensah","year":"2019","journal-title":"Circulation"},{"key":"R13-20260518","first-page":"731","article-title":"Social determinants of health and cardiovascular disease","volume":"8","author":"Vart","year":"2019","journal-title":"J Clin Med"},{"key":"R14-20260518","first-page":"925","article-title":"Dynamic changes in cardiac troponin I in patients with acute myocardial infarction","volume":"106","author":"Morrow","year":"2010","journal-title":"Am J Cardiol"},{"key":"R15-20260518","first-page":"425","article-title":"The role of H-FABP in the early diagnosis of acute myocardial infarction","volume":"37","author":"Giannitsis","year":"2004","journal-title":"Clin Biochem"},{"key":"R16-20260518","first-page":"11","article-title":"Heart-type fatty acid-binding protein: A new biomarker for cardiac ischemia","volume":"63","author":"Bergmann","year":"2017","journal-title":"Clin Lab"},{"key":"R17-20260518","first-page":"800","article-title":"Comparison of H-FABP with conventional cardiac biomarkers in patients with acute coronary syndrome","volume":"52","author":"Wu","year":"2006","journal-title":"Clin Chem"},{"key":"R18-20260518","first-page":"462","article-title":"The prognostic value of heart-type fatty acid-binding protein in patients with acute coronary syndrome","volume":"71","author":"Karp","year":"2018","journal-title":"J Cardiol"},{"key":"R19-20260518","first-page":"1208","article-title":"Clinical outcomes in patients with advanced heart failure","volume":"70","author":"Smith","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"R20-20260518","first-page":"2145","article-title":"The impact of hormonal therapies on cardiovascular disease outcomes","volume":"141","author":"Doe","year":"2020","journal-title":"Circulation"},{"key":"R21-20260518","first-page":"210","article-title":"Assessing the relationship between inflammation and heart disease","volume":"105","author":"Johnson","year":"2019","journal-title":"Heart"},{"key":"R22-20260518","first-page":"191","article-title":"A novel approach to cardiovascular risk management","volume":"77","author":"Brown","year":"2021","journal-title":"J Cardiol"},{"key":"R23-20260518","first-page":"940","article-title":"Long-term outcomes of coronary artery disease","volume":"42","author":"Miller","year":"2021","journal-title":"Eur Heart J"},{"key":"R24-20260518","first-page":"112","article-title":"Advances in heart failure treatment","volume":"88","author":"Davis","year":"2022","journal-title":"Int J Cardiol"},{"key":"R25-20260518","first-page":"657","article-title":"Efficacy of new antiplatelet agents in cardiovascular disease","volume":"384","author":"Wilson","year":"2021","journal-title":"N Engl J Med"},{"key":"R26-20260518","first-page":"134","article-title":"Socioeconomic factors associated with cardiovascular disease outcomes","volume":"21","author":"Taylor","year":"2021","journal-title":"BMC Cardiovasc Disord"},{"key":"R27-20260518","first-page":"89","article-title":"The impact of lifestyle changes on heart health","volume":"196","author":"Anderson","year":"2018","journal-title":"Am Heart J"},{"key":"R28-20260518","first-page":"1204","article-title":"Relationship between diet and cardiovascular risks","volume":"150","author":"Lee","year":"2020","journal-title":"J Nutr"},{"key":"R29-20260518","first-page":"41","article-title":"Analyzing public health trends in cardiac disease","volume":"32","author":"Robinson","year":"2021","journal-title":"Health Rep"},{"key":"R30-20260518","first-page":"e020389","article-title":"The role of genetics in heart disease","volume":"10","author":"Harris","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"R31-20260518","first-page":"918","article-title":"Trends in myocardial infarction management","volume":"92","author":"Deborah","year":"2006","journal-title":"Heart"},{"key":"R32-20260518","first-page":"1169","article-title":"Medication adherence in cardiovascular disease: A review","volume":"33","author":"Antonia","year":"2012","journal-title":"Eur Heart J"},{"key":"R33-20260518","first-page":"1452","article-title":"Risk assessment in coronary artery disease","volume":"105","author":"Albarran","year":"2002","journal-title":"Circulation"},{"key":"R34-20260518","first-page":"134","article-title":"Contemporary approaches to arrhythmia management","volume":"40","author":"Martinez","year":"2019","journal-title":"J Clin Cardiol"},{"key":"R35-20260518","first-page":"1347","article-title":"Vascular health in diabetic populations","volume":"35","author":"Nguyen","year":"2020","journal-title":"Heart Vessels"},{"key":"R36-20260518","first-page":"107854","article-title":"Diabetic cardiomyopathy: Pathophysiology and treatment","volume":"35","author":"O'Brien","year":"2021","journal-title":"J Diabetes Complicat"},{"key":"R37-20260518","first-page":"273","article-title":"Advances in electrocardiography for heart failure","volume":"36","author":"Thompson","year":"2003","journal-title":"J Electrocardiol"},{"key":"R38-20260518","first-page":"1156","article-title":"Echocardiographic assessment of heart disease","volume":"22","author":"Williams","year":"2009","journal-title":"J Am Soc Echocardiogr"},{"key":"R39-20260518","first-page":"927","article-title":"Biomarker discovery for cardiovascular risk assessment","volume":"62","author":"Xu","year":"2016","journal-title":"Clin Chem"},{"key":"R40-20260518","first-page":"213","article-title":"Evaluation of cardiovascular transplant outcomes","volume":"14","author":"Young","year":"2021","journal-title":"J Cardiovasc Trans Res"},{"key":"R41-20260518","first-page":"521","article-title":"The role of laboratory tests in cardiovascular disease","volume":"57","author":"Zhang","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"R42-20260518","first-page":"343","article-title":"Exploring advances in cardiovascular medicine","volume":"23","author":"Adams","year":"2022","journal-title":"J Cardiovasc Med"},{"key":"R43-20260518","first-page":"25","article-title":"Innovations in diagnostic methods for cardiovascular health","volume":"2","author":"Becker","year":"2021","journal-title":"Rapid Diagn Lab Med"}],"container-title":["International Journal of Critical Illness and Injury Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_63_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:15:28Z","timestamp":1787760928000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijciis.ijciis_63_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,18]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijciis.ijciis_63_25","relation":{},"ISSN":["2229-5151","2231-5004"],"issn-type":[{"value":"2229-5151","type":"print"},{"value":"2231-5004","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,18]]},"assertion":[{"value":"2025-05-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}